12:03pm GSK Unit Launches Tender Offer for Nuvalent Acquisition MT
11:33am GSK Kicks Off Tender Offer to Buy Cancer Therapies Company Nuvalent MT
10:46am GSK launches tender offer for USD10.6 billion purchase of Nuvalent AN
09:58am GSK : announces commencement of tender offer to acquire Nuvalent, Inc. PU
06-23 GSK executives, including non-exec chair, buy shares AN
06-17 GSK says US FDA approves urinary tract infection treatment Utebzi AN
06-17 Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) BU
06-17 GSK Secures US FDA Nod for Complicated Urinary Tract Infection Antibiotic MT
06-17 GSK, Spero Therapeutics Get FDA Approval for Utebzi in Complicated Urinary Tract Infections MT
06-17 GSK : Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) PU
06-17 US FDA approves GSK's oral antibiotic for drug-resistant UTIs RE
06-16 GSK's Exdensur Wins Canadian Approval for Severe Asthma, Nasal Polyps MT
06-16 Saudi Chemical Co. Secures New Medical Marketing Services Deal from GSK Unit MT
06-15 GSK slips despite positive analysis from UBS Zonebourse
06-15 GSK : UBS remains Neutral ZD
06-12 GSK's Clonal Myeloid Disorder Treatment Gets Orphan Drug Designation From US, European Regulators MT
06-12 GSK drug momelotinib gains regulatory nods as VEXAS treatment AN
06-12 GSK's Momelotinib Receives US, EU Orphan Drug Designations for Vexas Syndrome MT
06-11 Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal RE
06-10 Intron Health Upgrades GSK to Hold Rating, Lifts PT MT
06-10 GSK : Deutsche Bank reiterates its Neutral rating ZD
06-10 GSK : UBS sticks Neutral ZD
06-09 British Shares Fall Back Amid Renewed Peace Talks; GSK to Buy Nuvalent MT
06-09 GSK : JP Morgan maintains a Sell rating ZD
06-09 WINNERS & LOSERS: GSK falls after Nuvalent buy; Molten Ventures jumps AN
No results match your criteria
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!